HK1183025A1 - -異丙基苯基山梨醇化合物的晶型及其製備方法 - Google Patents

-異丙基苯基山梨醇化合物的晶型及其製備方法

Info

Publication number
HK1183025A1
HK1183025A1 HK13110387.5A HK13110387A HK1183025A1 HK 1183025 A1 HK1183025 A1 HK 1183025A1 HK 13110387 A HK13110387 A HK 13110387A HK 1183025 A1 HK1183025 A1 HK 1183025A1
Authority
HK
Hong Kong
Prior art keywords
production
crystal form
glucitol compound
isopropylphenyl glucitol
isopropylphenyl
Prior art date
Application number
HK13110387.5A
Other languages
English (en)
Inventor
木村好博
伊村維晃
大崎尚人
松島步
Original Assignee
大正制藥株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大正制藥株式會社 filed Critical 大正制藥株式會社
Publication of HK1183025A1 publication Critical patent/HK1183025A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
HK13110387.5A 2010-08-20 2013-09-06 -異丙基苯基山梨醇化合物的晶型及其製備方法 HK1183025A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010184854 2010-08-20
JP2010189739 2010-08-26
PCT/JP2011/068736 WO2012023598A1 (ja) 2010-08-20 2011-08-19 4-イソプロピルフェニル グルシトール化合物の結晶形及びその製造方法

Publications (1)

Publication Number Publication Date
HK1183025A1 true HK1183025A1 (zh) 2013-12-13

Family

ID=45605250

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13110387.5A HK1183025A1 (zh) 2010-08-20 2013-09-06 -異丙基苯基山梨醇化合物的晶型及其製備方法

Country Status (13)

Country Link
US (1) US8822674B2 (zh)
EP (1) EP2607359A4 (zh)
JP (1) JP5656092B2 (zh)
KR (1) KR20130097711A (zh)
CN (1) CN103168035B (zh)
AU (1) AU2011291709B2 (zh)
CA (1) CA2807755A1 (zh)
HK (1) HK1183025A1 (zh)
RU (1) RU2013112368A (zh)
SG (1) SG187893A1 (zh)
TW (1) TW201219414A (zh)
WO (1) WO2012023598A1 (zh)
ZA (1) ZA201301034B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5817317B2 (ja) * 2010-08-20 2015-11-18 大正製薬株式会社 4−イソプロピルフェニルグルシトール化合物を有効成分として含有することを特徴とする糖尿病の予防又は治療剤
RU2648467C2 (ru) * 2013-02-04 2018-03-26 Тайсо Фармасьютикал Ко., Лтд. Профилактическое или терапевтическое лекарственное средство для лечения запора
JP2019142774A (ja) * 2016-06-20 2019-08-29 大正製薬株式会社 腸内環境改善剤
CA3051095A1 (en) 2017-01-23 2018-07-26 Naqi Logics, Llc Apparatus, methods, and systems for using imagined direction to define actions, functions, or execution
JP7156154B2 (ja) * 2019-04-18 2022-10-19 株式会社島津製作所 培地処理システム及び培地処理方法
CN110183576B (zh) * 2019-06-04 2021-10-22 万华化学(四川)有限公司 一种可用于附聚的生产聚丁二烯胶乳的乳化剂、其制备方法及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1400529A4 (en) 2001-05-30 2007-12-19 Kissei Pharmaceutical GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL AND INTERMEDIARY USE THEREOF
ZA200501094B (en) * 2002-08-08 2006-10-25 Kissei Pharmaceutical Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
DE60332743D1 (de) 2002-08-08 2010-07-08 Kissei Pharmaceutical Pyrazolderivat, dieses enthaltende medizinische zusammensetzung, medizinische verwendung davon, und zwischenprodukt für dessen herstellung
JP2004137245A (ja) 2002-08-23 2004-05-13 Kissei Pharmaceut Co Ltd ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
JP4606876B2 (ja) 2002-08-27 2011-01-05 キッセイ薬品工業株式会社 ピラゾール誘導体、それを含有する医薬組成物及びその医薬用途
CN1744916A (zh) 2002-12-04 2006-03-08 橘生药品工业株式会社 预防和治疗高血糖所导致的疾病
DE102004028241B4 (de) 2004-06-11 2007-09-13 Sanofi-Aventis Deutschland Gmbh Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
AU2007252432B2 (en) * 2006-05-19 2011-11-17 Taisho Pharmaceutical Co., Ltd. C-phenyl glycitol compound
JP2009107997A (ja) * 2007-10-31 2009-05-21 Taisho Pharmaceutical Co Ltd (1s)−1,5−アンヒドロ−1−[5−(4−エトキシベンジル)−2−メトキシ−4−メチルフェニル]−1−チオ−d−グルシトールの結晶形とその製造方法
US8466113B2 (en) * 2009-02-23 2013-06-18 Taisho Pharmaceutical Co., Ltd. 4-isopropylphenyl glucitol compounds as SGLT1 inhibitors

Also Published As

Publication number Publication date
TW201219414A (en) 2012-05-16
CN103168035B (zh) 2016-01-20
WO2012023598A1 (ja) 2012-02-23
AU2011291709A1 (en) 2013-03-07
ZA201301034B (en) 2014-04-30
SG187893A1 (en) 2013-03-28
US8822674B2 (en) 2014-09-02
JPWO2012023598A1 (ja) 2013-10-28
JP5656092B2 (ja) 2015-01-21
CA2807755A1 (en) 2012-02-23
EP2607359A4 (en) 2014-01-15
EP2607359A1 (en) 2013-06-26
RU2013112368A (ru) 2014-09-27
US20130144050A1 (en) 2013-06-06
AU2011291709B2 (en) 2014-03-27
KR20130097711A (ko) 2013-09-03
CN103168035A (zh) 2013-06-19

Similar Documents

Publication Publication Date Title
IL268953B (en) A process to form cycloalkylcarboxamido indole compounds
HK1178688A1 (zh) 連接結構體的製造方法
EP2581067A4 (en) PROCESS FOR PRODUCING AN ABSORBENT PRODUCT
EP2548868A4 (en) METHOD FOR PRODUCING DEUTERATED OMEGA DIPHENYL UREA
PL2744768T3 (pl) Sposób wytwarzania klinkieru zawierającego ternezyt
EP2762465A4 (en) INTERMEDIATE PRODUCT FOR THE PREPARATION OF A POLYMERIZABLE COMPOUND AND METHOD FOR THE PRODUCTION THEREOF
EP2554628A4 (en) SURFACE TREATED FLUORESCENT BODIES AND PROCESS FOR PRODUCING SURFACE TREATED FLUORESCENT BODIES
EP2548879A4 (en) DIAMINE DERIVATIVE CRYSTAL AND METHOD OF PRODUCING THE SAME
EP2798063A4 (en) PREPARATION OF DIHYDROSTERCULINIC ACID AND DERIVATIVES THEREOF
EP2345624A4 (en) MAYENIC COMPOUND AND MANUFACTURING METHOD THEREFOR
ZA201309699B (en) Process for production of synthesis gas
PT2354117E (pt) Processo para a produção contínua de nitrobenzeno
HK1183025A1 (zh) -異丙基苯基山梨醇化合物的晶型及其製備方法
EP2546822A4 (en) METHOD FOR PRODUCING A DISPLAY DEVICE
EP2540836A4 (en) PROCESS FOR THE PRODUCTION OF CADAVERINE
HK1188414A1 (zh) 種生產超疏水性表面的新方法
EP2623580A4 (en) PROCESS FOR PRODUCING BETA-SIALON
EP2589662A4 (en) Process for production of useful substance
EP2697334A4 (en) PROCESS FOR THE PRODUCTION OF RETAINING AGENTS
HUE044066T2 (hu) Eljárás metilén-difenil-diizocianát elõállítására
ZA201208193B (en) Nano-wires made of novel precursors and method for thr production thereof
EP2423187A4 (en) PROCESS FOR PRODUCING N-ALCOXYCARBONYL-tert-LEUCINS
EP2633058A4 (en) PROCESS FOR MASS PRODUCTION OF FACTOR VII / VIIA
PL2689069T3 (pl) Proces produkcji podsypki (balastu)
IL215930A0 (en) Novel crystal form of tricyclic benzopyran compound and production method thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220819